DanCann Pharma A/S: The exercise period for warrants of series TO 2 begins today
COPENHAGEN, Denmark, 16 May 2023 - DanCann Pharma A/S (SS: DANCAN) ("DanCann Pharma" or the "Company"), a Danish company powered by cannabinoids, hereby announces that Today is the first day of the exercise period for DanCann Pharma’s warrants of series TO 2 which were issued in connection with the Company’s rights issue of units that was announced on 21 October 2022. Holders of warrants of series TO 2 have, for each warrant, the right to subscribe for one (1) new share in DanCann Pharma at a price of DKK 0.36 per share. The exercise period runs until and including 31 May 2023.Information